← Back to all trials
Not Yet Recruiting
NCT07039539
Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial
Conditions: Drug Abuse, Harm Reduction, Minimization, Harm, Anabolic Steroids Adverse Events, Brief Intervention
Sex: All
Ages: 15 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 32
Sponsor: University of Sao Paulo
Location: Clinical Hospital of the School of Medicine, University of Sao Paulo São Paulo São Paulo
Summary
This clinical trial aims to investigate the short and long-term efficacy of a harm reduction intervention in reducing the use of non-clinical anabolic-androgenic steroids (AAS) in abusive users of AAS. As secondary objectives, the study will investigate the intervention's effect on health parameters (i.e., blood), quality of life, sleep quality, body image, eating behavior, depression, anxiety, fatigue, aggressiveness, cardiovascular parameters, muscle strength, body composition and muscle cross-sectional area outcomes.
Eligibility Criteria
Inclusion Criteria:
* Anyone over 15 years of age;
* Planning to use/increase the dose of AAS for aesthetic and/or physical performance purposes;
* Plan to use/increase the dose of AAS during eight to twelve weeks.
Exclusion Criteria:
* Medical prescription for AAS use;
* Use for sexual reassignment.
Source: ClinicalTrials.gov (NCT07039539). StuddyBuddy aggregates publicly available trial information.